Abbonarsi

SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome - 05/04/21

Doi : 10.1016/j.jaci.2021.02.001 
Christian Rosas-Salazar, MD, MPH a, , Kyle S. Kimura, MD b, , Meghan H. Shilts, MHS, MS c, Britton A. Strickland, BS c, d, Michael H. Freeman, MD b, Bronson C. Wessinger, BE e, Veerain Gupta, MS e, Hunter M. Brown, MS c, Seesandra V. Rajagopala, PhD c, Justin H. Turner, MD, PhD b, , Suman R. Das, PhD b, c,
a Division of Allergy, Immunology, and Pulmonary Medicine, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tenn 
b Department of Otolaryngology - Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tenn 
c Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn 
d Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tenn 
e Vanderbilt University School of Medicine, Nashville, Tenn 

Corresponding author: Justin H. Turner, MD, PhD, Department of Otolaryngology - Head and Neck Surgery, Vanderbilt University Medical Center, 1215 21st Avenue South, Medical Center East, Ste 7209, Nashville, TN 37232.Department of Otolaryngology - Head and Neck SurgeryVanderbilt University Medical CenterMedical Center East1215 21st Avenue SouthSte 7209NashvilleTN37232∗∗Suman R. Das, PhD, Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, 1161 21st Avenue South, Medical Center North, Ste A2200, Nashville, TN 37232.Division of Infectious DiseasesDepartment of MedicineVanderbilt University Medical CenterMedical Center North1161 21st Avenue SouthSte A2200NashvilleTN37232

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.

Si connetta per beneficiarne

Abstract

Background

Little is known about the relationships between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the respiratory virus responsible for the ongoing coronavirus disease 2019 (COVID-19) pandemic, and the upper respiratory tract (URT) microbiome.

Objective

We sought to compare the URT microbiome between SARS-CoV-2–infected and –uninfected adults and to examine the association of SARS-CoV-2 viral load with the URT microbiome during COVID-19.

Methods

We characterized the URT microbiome using 16S ribosomal RNA sequencing in 59 adults (38 with confirmed, symptomatic, mild to moderate COVID-19 and 21 asymptomatic, uninfected controls). In those with COVID-19, we measured SARS-CoV-2 viral load using quantitative reverse transcription PCR. We then examined the association of SARS-CoV-2 infection status and its viral load with the ⍺-diversity, β-diversity, and abundance of bacterial taxa of the URT microbiome. Our main models were all adjusted for age and sex.

Results

The observed species index was significantly higher in SARS-CoV-2–infected than in –uninfected adults (β linear regression coefficient = 7.53; 95% CI, 0.17-14.89; P = .045). In differential abundance testing, 9 amplicon sequence variants were significantly different in both of our comparisons, with Peptoniphilus lacrimalis, Campylobacter hominis, Prevotella 9 copri, and an Anaerococcus unclassified amplicon sequence variant being more abundant in those with SARS-CoV-2 infection and in those with high viral load during COVID-19, whereas Corynebacterium unclassified, Staphylococcus haemolyticus, Prevotella disiens, and 2 Corynebacterium_1 unclassified amplicon sequence variants were more abundant in those without SARS-CoV-2 infection and in those with low viral load during COVID-19.

Conclusions

Our findings suggest complex associations between SARS-CoV-2 and the URT microbiome in adults. Future studies are needed to examine how these viral-bacterial interactions can impact the clinical progression, severity, and recovery of COVID-19.

Il testo completo di questo articolo è disponibile in PDF.

Key words : 16S rRNA sequencing, coronavirus, COVID-19, microbiome, nasal, nasopharynx, respiratory, SARS-CoV-2

Abbreviations used : ASV, COVID-19, LRT, SARS-CoV-2, URT


Mappa


 This study is being submitted as an abstract to the American Thoracic Society International Conference 2021 (San Diego, Calif).
 This work was supported by funds from the National Institute of Allergy and Infectious Diseases (under award nos. R21AI142321, R21AI154016, and R21AI149262); the National Heart, Lung, and Blood Institute (under award nos. K23HL148638 and R01HL146401); and the Vanderbilt Technologies for Advanced Genomics Core (grant support from the National Institutes of Health under award nos. UL1RR024975, P30CA68485, P30EY08126, and G20RR030956). The contents are solely the responsibility of the authors and do not necessarily represent official views of the funding agencies.
 Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest.


© 2021  American Academy of Allergy, Asthma & Immunology. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 147 - N° 4

P. 1226 - Aprile 2021 Ritorno al numero
Articolo precedente Articolo precedente
  • Efficacy of early anti-inflammatory treatment with high doses of intravenous anakinra with or without glucocorticoids in patients with severe COVID-19 pneumonia
  • Emanuele Pontali, Stefano Volpi, Alessio Signori, Giancarlo Antonucci, Marco Castellaneta, Davide Buzzi, Amedeo Montale, Marta Bustaffa, Alessia Angelelli, Roberta Caorsi, Elisa Giambruno, Nicoletta Bobbio, Marcello Feasi, Ilaria Gueli, Francesca Tricerri, Francesca Calautti, Elio Castagnola, Andrea Moscatelli, Gian Andrea Rollandi, Angelo Ravelli, Giovanni Cassola, Maria Pia Sormani, Marco Gattorno
| Articolo seguente Articolo seguente
  • Effect of early and late prenatal vitamin D and maternal asthma status on offspring asthma or recurrent wheeze
  • Mengdi Lu, Augusto A. Litonjua, George T. O’Connor, Robert S. Zeiger, Leonard Bacharier, Michael Schatz, Vincent J. Carey, Scott T. Weiss, Hooman Mirzakhani

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.